Access to Heart Failure Medicines in Low- and Middle-Income Countries: An Analysis of Essential Medicines Lists, Availability, Price, and Affordability.
作者信息
Agarwal Anubha, Husain Muhammad Jami, Datta Biplab, Kishore Sandeep P, Huffman Mark D
机构信息
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (A.A.).
Global Noncommunicable Diseases Branch, Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA (M.J.H.).
出版信息
Circ Heart Fail. 2022 Apr;15(4):e008971. doi: 10.1161/CIRCHEARTFAILURE.121.008971. Epub 2022 Mar 7.
Abstract
摘要
相似文献
1
Access to Heart Failure Medicines in Low- and Middle-Income Countries: An Analysis of Essential Medicines Lists, Availability, Price, and Affordability.低收入和中等收入国家的心力衰竭药物获取情况：基本药物清单、可及性、价格及可负担性分析
Circ Heart Fail. 2022 Apr;15(4):e008971. doi: 10.1161/CIRCHEARTFAILURE.121.008971. Epub 2022 Mar 7.
2
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.发展中国家心血管疾病和高血压药物的可及性：基本药物清单、价格、可获得性及可负担性分析
J Am Heart Assoc. 2020 May 5;9(9):e015302. doi: 10.1161/JAHA.119.015302. Epub 2020 Apr 25.
3
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.绘制全球范围内精神健康状况基本药物的选择、可得性、价格和可负担性图谱。
Epidemiol Psychiatr Sci. 2022 Apr 19;31:e22. doi: 10.1017/S2045796022000087.
4
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.高收入、中等收入和低收入国家的糖尿病基本药物的可及性和可负担性：一项前瞻性流行病学研究。
Lancet Diabetes Endocrinol. 2018 Oct;6(10):798-808. doi: 10.1016/S2213-8587(18)30233-X. Epub 2018 Aug 28.
5
An Analysis of Accessibility of Representative Psychotropic Medicine From the World Health Organization Model List of Essential Medicines in Developing Countries With Different Income Levels.不同收入水平发展中国家可获取世界卫生组织基本药物示范目录中代表性精神药物情况分析
Value Health. 2023 Apr;26(4):528-535. doi: 10.1016/j.jval.2022.11.009. Epub 2022 Nov 26.
6
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis.54个低收入和中等收入国家成人药品的价格、可及性和可负担性：基于二次分析的证据
Lancet Glob Health. 2025 Jan;13(1):e50-e58. doi: 10.1016/S2214-109X(24)00442-X.
7
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.中低收入国家哮喘和 COPD 基本药物的可及性、成本和可负担性：系统评价。
Lancet Glob Health. 2022 Oct;10(10):e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8.
8
Accessibility of essential anticancer medicines for children in the Sichuan Province of China.中国四川省儿童基本抗癌药物的可及性。
Front Public Health. 2022 Nov 4;10:980969. doi: 10.3389/fpubh.2022.980969. eCollection 2022.
9
The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.六个低收入和中等收入国家中某些慢性病基本药物的可获得性和可负担性。
Bull World Health Organ. 2007 Apr;85(4):279-88. doi: 10.2471/blt.06.033647.
10
Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study.喀麦隆西南部基本心血管疾病药物的可及性、成本和可负担性：来自喀麦隆疾病研究科学的初步发现。
PLoS One. 2020 Mar 4;15(3):e0229307. doi: 10.1371/journal.pone.0229307. eCollection 2020.
引用本文的文献
1
Global heart failure epidemiology versus enrolment in pivotal trials: A formidable mismatch.全球心力衰竭流行病学与关键试验的入组情况：严重不匹配。
Eur J Heart Fail. 2025 May 28. doi: 10.1002/ejhf.3707.
2
Emerging risk factors for heart failure in younger populations: A growing public health concern.年轻人群中心力衰竭的新兴风险因素：日益受到关注的公共卫生问题。
World J Cardiol. 2025 Apr 26;17(4):104717. doi: 10.4330/wjc.v17.i4.104717.
3
A STRONG call for intensive oral heart failure therapy in acute heart failure patients.对急性心力衰竭患者进行强化口服心力衰竭治疗的强烈呼吁。
Heart Fail Rev. 2025 May;30(3):537-543. doi: 10.1007/s10741-025-10486-2. Epub 2025 Jan 24.
4
Diagnostic and therapeutic practice for HFpEF across continents and regions: An international survey.全球各大洲和地区射血分数保留的心力衰竭的诊断和治疗实践：一项国际调查。
ESC Heart Fail. 2025 Feb;12(1):487-496. doi: 10.1002/ehf2.15084. Epub 2024 Oct 1.
5
Use of Guideline-Recommended Heart Failure Drugs in High-, Middle-, and Low-Income Countries: A Systematic Review and Meta-Analysis.高、中、低收入国家中指南推荐的心力衰竭药物的使用：一项系统评价和荟萃分析。
Glob Heart. 2024 Sep 12;19(1):74. doi: 10.5334/gh.1355. eCollection 2024.
6
Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in India: A Convergent Parallel Mixed Methods Study.心力衰竭伴射血分数降低的印度多效药丸实施策略：一项汇聚平行混合方法研究。
Glob Heart. 2024 Aug 26;19(1):69. doi: 10.5334/gh.1348. eCollection 2024.
7
Management of Heart Failure in a Resource-Limited Setting: Expert Opinion from India.资源有限环境下的心力衰竭管理：来自印度的专家意见
Cardiol Ther. 2024 Jun;13(2):243-266. doi: 10.1007/s40119-024-00367-4. Epub 2024 Apr 30.
8
Recent successes in heart failure treatment.心力衰竭治疗的最新进展。
Nat Med. 2023 Oct;29(10):2424-2437. doi: 10.1038/s41591-023-02567-2. Epub 2023 Oct 9.
9
Access to cardiovascular medicines in low- and middle-income countries: a mini review.中低收入国家的心血管药物可及性：小型综述。
Glob Health Res Policy. 2023 May 23;8(1):17. doi: 10.1186/s41256-023-00301-6.
本文引用的文献
1
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries.21 个高收入、中等收入和低收入国家的药品可及性和可负担性与心血管结局的关系。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-002640.
2
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.发展中国家心血管疾病和高血压药物的可及性：基本药物清单、价格、可获得性及可负担性分析
J Am Heart Assoc. 2020 May 5;9(9):e015302. doi: 10.1161/JAHA.119.015302. Epub 2020 Apr 25.
3
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.按世界地区、收入水平和收入差距划分的因心力衰竭住院患者出院后的预后（REPORT-HF）：一项队列研究。
Lancet Glob Health. 2020 Mar;8(3):e411-e422. doi: 10.1016/S2214-109X(20)30004-8.
4
Essential medicines are more available than other medicines around the globe.在全球范围内，基本药物比其他药物更容易获得。
PLoS One. 2014 Feb 12;9(2):e87576. doi: 10.1371/journal.pone.0087576. eCollection 2014.
Zotero 插件